COA KVR-2026-28597D matches Kovera Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
DO70P9Label 10 mg · Lab measured 13.1 mg
131% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 3.3 mg using the measured mass, against 2.5 mg on the label — 31% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | KVR-2026-28597D |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 28 Aug 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | Kovera Labs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of PT-141 from peptide partners, performed by Kovera Labs on June 25, 2026. Reported purity: 99.742%. Net content: 13.1 mg against 10 mg labeled (131% of label). Tested content exceeds the labeled amount by 31%. Endotoxins: ≤0.5 EU/mL Pass. Heavy metals: Arsenic <0.15, Cadmium <0.05, Lead <0.5, Mercury <0.3. Batch PT202605. Sample source: shop-provided. Certificate of analysis attached.
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| PT202512 | 12 Jan 2026 | BioRegen | 99.89% | 110% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion